Cancer diagnosis stories

Jul 23, 2026

Advanced Testing Methods Show Promise in Detecting Lung Cancer Biomarkers and Monitoring Disease

New research demonstrates that RNA-based testing can improve detection of MET exon 14 skipping mutations in lung cancer patients, while circulating tumor DNA (ctDNA) testing is increasingly being adopted for early cancer detection and treatment monitoring across oncology.

Jul 23, 2026·2 sources

May 30, 2026

DNA Test Could Allow Millions of Breast Cancer Patients to Safely Avoid Chemotherapy

Scientists have developed a DNA test that can distinguish between breast cancer patients who are likely to benefit from chemotherapy and those who can safely avoid it, potentially sparing millions from unnecessary treatment.

May 30, 2026·1 source

Apr 21, 2026

Blood Test Detects Aggressive Brain Tumors Early and Could Reduce Need for Risky Surgery

University of Sussex researchers, in collaboration with international scientists, identified a blood test capable of early diagnosis of the most aggressive form of brain cancer, potentially eliminating the need for dangerous surgical biopsies.

Apr 21, 2026·1 source

Top claims

▪Detecting circulating tumor DNA is more challenging in patients who have kidney, prostate, and thyroid cancers.
▪A study found that the circulating tumor DNA detection rate for prostate cancer is over 77%, compared to over 90% in other cancer types.
▪A multinational external quality assessment scheme showed a 98% success rate for tissue-based testing of MET exon 14 alterations across laboratories.

Subtopics

Biomarkers & bloodwork testing Genetic testing Precision medicine Cancer treatment breakthroughs Brain health & dementia researchers

Related timelines

Cancer diagnosis stories

Advanced Testing Methods Show Promise in Detecting Lung Cancer Biomarkers and Monitoring Disease

DNA Test Could Allow Millions of Breast Cancer Patients to Safely Avoid Chemotherapy

Blood Test Detects Aggressive Brain Tumors Early and Could Reduce Need for Risky Surgery

Related timelines

Iran War

US Congress

Venture capital funding

Strait of Hormuz blockage

Trump administration